Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers

Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers

US Patent 10000487 · Granted Jun 19, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ASGPR cell surface receptor binding compounds and conjugates2025
TLR7 agonists2025
Substituted purines as TLR7 agonists2024
Crystalline forms of Mnk inhibitors2024
Crystalline forms of Mnk inhibitors2024
Crystalline forms of Mnk inhibitors2024
Piperidine-substituted Mnk inhibitors and methods related thereto2024
Piperidine-substituted Mnk inhibitors and methods related thereto2024
TLR7 agonists2023
EIF4A-inhibiting compounds and methods related thereto2022
EIF4A-inhibiting compounds and methods related thereto2022
EIF4E-inhibiting compounds and methods2022